{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:13:10Z","timestamp":1788250390254,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["178533"],"award-info":[{"award-number":["178533"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000082","name":"Cystic Fibrosis Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000082","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jcf.2023.11.014","type":"journal-article","created":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T07:41:37Z","timestamp":1701589297000},"page":"823-830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Measuring the burden of cystic fibrosis: A scoping review"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9150-6303","authenticated-orcid":false,"given":"Zain M.","family":"Cheema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian C.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier D.","family":"Laflamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey R.","family":"Rabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wallenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-8451","authenticated-orcid":false,"given":"Stephanie Y.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1785-3870","authenticated-orcid":false,"given":"Bradley S.","family":"Quon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4529-5653","authenticated-orcid":false,"given":"Anne L.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Dominika","family":"Wranik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Sadatsafavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7931-8051","authenticated-orcid":false,"given":"Sanja","family":"Stanojevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcf.2023.11.014_bib0001","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respiratory Med"},{"issue":"8","key":"10.1016\/j.jcf.2023.11.014_bib0002","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7326\/M16-0858","article-title":"Survival comparison of patients with cystic fibrosis in Canada and the United States: a population-based cohort study","volume":"166","author":"Stephenson","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcf.2023.11.014_bib0003","series-title":"Cystic fibrosis foundation patient registry annual data report","year":"2021"},{"key":"10.1016\/j.jcf.2023.11.014_bib0004","unstructured":"Canada C.F. Annual registry report: cystic fibrosis Canada, 2021."},{"key":"10.1016\/j.jcf.2023.11.014_bib0005","unstructured":"Trust UC UK CF registry annual data report. 2020."},{"issue":"7","key":"10.1016\/j.jcf.2023.11.014_bib0006","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.healthpol.2014.12.016","article-title":"Socio-economic burden of rare diseases: a systematic review of cost of illness evidence","volume":"119","author":"Angelis","year":"2015","journal-title":"Health Policy (New York)"},{"issue":"2","key":"10.1016\/j.jcf.2023.11.014_bib0007","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40258-015-0211-4","article-title":"A scoping review of healthcare costs for patients with cystic fibrosis","volume":"14","author":"Hollin","year":"2016","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.jcf.2023.11.014_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/17534666221086416","article-title":"Caregiver burden in cystic fibrosis: a systematic literature review","volume":"16","author":"Daly","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.jcf.2023.11.014_bib0009","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jcf.2023.11.014_bib0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jcf.2023.11.014_bib0011","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jclinepi.2013.08.005","article-title":"Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health","volume":"67","author":"O'Neill","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.jcf.2023.11.014_bib0012","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3350\/cmh.2014.20.4.327","article-title":"Cost-of-illness studies: concepts, scopes, and methods","volume":"20","author":"Jo","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jcf.2023.11.014_bib0013","unstructured":"Oanada Currency Converter Foreign Exchange Rate. https:\/\/www.oanda.com\/currency-converter\/en\/?from=EUR&to=USD&amount=1."},{"key":"10.1016\/j.jcf.2023.11.014_bib0014","unstructured":"Finance Inflation Calculator. https:\/\/www.officialdata.org\/."},{"issue":"3","key":"10.1016\/j.jcf.2023.11.014_bib0015","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.5504\/bbeq.2013.0029","article-title":"A health-related quality of life and pharmacotherapy costs study for patients with cystic fybrosis, gaucher disease and chronic myeloid leukemia in Bulgaria","volume":"27","author":"Kamusheva","year":"2013","journal-title":"Biotechnol Biotechnol Equip"},{"issue":"1","key":"10.1016\/j.jcf.2023.11.014_bib0016","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jcf.2021.03.025","article-title":"Temporal trends in healthcare resource use and associated costs of patients with cystic fibrosis","volume":"21","author":"Durieu","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2023.11.014_bib0017","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/21548331.2018.1505407","article-title":"Hospitalization costs of cystic fibrosis in the United States: a retrospective analysis","volume":"46","author":"Vadagam","year":"2018","journal-title":"Hosp Pract (1995)"},{"issue":"7","key":"10.1016\/j.jcf.2023.11.014_bib0018","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10198-014-0621-5","article-title":"Cost of care for cystic fibrosis: an investigation of cost determinants using national registry data","volume":"16","author":"Gu","year":"2015","journal-title":"Eur J Health Econ"},{"issue":"4","key":"10.1016\/j.jcf.2023.11.014_bib0019","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1017\/S0266462306051476","article-title":"Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France","volume":"22","author":"Horvais","year":"2006","journal-title":"Int J Technol Assess Health Care"},{"issue":"5","key":"10.1016\/j.jcf.2023.11.014_bib0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcf.2008.02.004","article-title":"Evolution of costs of care for cystic fibrosis patients after clinical guidelines implementation in a French network","volume":"7","author":"Huot","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"10","key":"10.1016\/j.jcf.2023.11.014_bib0021","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s40273-017-0530-4","article-title":"Estimating direct cost of cystic fibrosis care using irish registry healthcare resource Utilisation data, 2008-2012","volume":"35","author":"Jackson","year":"2017","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.jcf.2023.11.014_bib0022","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/03007995.2016.1277196","article-title":"Frequency and costs of pulmonary exacerbations in patients with cystic fibrosis in the United States","volume":"33","author":"Rubin","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.jcf.2023.11.014_bib0023","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/ppul.25251","article-title":"An evaluation of healthcare utilization and clinical charges in children and adults with cystic fibrosis","volume":"56","author":"Perkins","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2023.11.014_bib0024","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jval.2011.11.027","article-title":"Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial","volume":"15","author":"DeWitt","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.jcf.2023.11.014_bib0025","article-title":"Healthcare resource utilization (HCRU) and clinical characteristics of medicaid patients with cystic fibrosis (CF)","volume":"22","author":"Hassan","year":"2016","journal-title":"J Manag Care Spec Pharmacy"},{"issue":"6","key":"10.1016\/j.jcf.2023.11.014_bib0026","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1542\/peds.103.6.e72","article-title":"The cost of medical care for patients with cystic fibrosis in a health maintenance organization","volume":"103","author":"Lieu","year":"1999","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.jcf.2023.11.014_bib0027","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1002\/ppul.25535","article-title":"Healthcare resource utilization and costs among children with cystic fibrosis in the United States","volume":"56","author":"Thorat","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.jcf.2023.11.014_bib0028","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5582\/irdr.2017.01043","article-title":"Nationwide trends of hospitalizations for cystic fibrosis in the United States from 2003 to 2013","volume":"6","author":"Agrawal","year":"2017","journal-title":"Intractab Rare Diseas Res"},{"issue":"3","key":"10.1016\/j.jcf.2023.11.014_bib0029","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ppul.21364","article-title":"Resource usage in outpatient care and reimbursement for cystic fibrosis in Germany","volume":"46","author":"Eidt-Koch","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"10.1016\/j.jcf.2023.11.014_bib0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ppul.21090","article-title":"Healthcare expenditures for privately insured people with cystic fibrosis","volume":"44","author":"Ouyang","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.11.014_bib0031","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.puhe.2017.03.003","article-title":"Costs of treatment of adult patients with cystic fibrosis in Poland and internationally","volume":"148","author":"Kopciuch","year":"2017","journal-title":"Public Health (Elsevier)"},{"issue":"5","key":"10.1016\/j.jcf.2023.11.014_bib0032","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00151829-200605050-00006","article-title":"Economic burden of ambulatory and home-based care for adults with cystic fibrosis","volume":"5","author":"Guerriere","year":"2006","journal-title":"Treat Respir Med"},{"issue":"1","key":"10.1016\/j.jcf.2023.11.014_bib0033","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1515\/folmed-2015-0020","article-title":"Economic burden and health-related quality of life of patients with cystic fibrosis in Bulgaria","volume":"57","author":"Iskrov","year":"2015","journal-title":"Folia Med (Plovdiv)"},{"issue":"1","key":"10.1016\/j.jcf.2023.11.014_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-015-1061-3","article-title":"Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom","volume":"15","author":"Angelis","year":"2015","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"10.1016\/j.jcf.2023.11.014_bib0035","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jcf.2014.11.006","article-title":"Costs and health-related quality of life of patients with cystic fibrosis and their carers in France","volume":"14","author":"Chevreul","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2023.11.014_bib0036","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10198-016-0781-6","article-title":"Social\/economic costs and health-related quality of life in patients with cystic fibrosis in Europe","volume":"17","author":"Chevreul","year":"2016","journal-title":"Eur J Health Econ"},{"issue":"1","key":"10.1016\/j.jcf.2023.11.014_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2191-1991-1-10","article-title":"Staff costs of hospital-based outpatient care of patients with cystic fibrosis","volume":"1","author":"Hollmeyer","year":"2011","journal-title":"Health Econ Rev"},{"issue":"12","key":"10.1016\/j.jcf.2023.11.014_bib0038","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/ppul.24178","article-title":"Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010-2016","volume":"53","author":"Grosse","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.11.014_bib0039","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12955-015-0224-6","article-title":"Mapping the EQ-5D index from the cystic fibrosis questionnaire-revised using multiple modelling approaches","volume":"13","author":"Acaster","year":"2015","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"10.1016\/j.jcf.2023.11.014_bib0040","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/thx.47.9.684","article-title":"A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients","volume":"47","author":"Robson","year":"1992","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.jcf.2023.11.014_bib0041","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/thx.51.3.298","article-title":"Cost of care of patients with cystic fibrosis in The Netherlands in 1990-1","volume":"51","author":"Wildhagen","year":"1996","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.jcf.2023.11.014_bib0042","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1183\/09031936.96.09112215","article-title":"The nonhospital costs of care of patients with CF in The Netherlands: results of a questionnaire","volume":"9","author":"Wildhagen","year":"1996","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.jcf.2023.11.014_bib0043","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1592\/phco.19.15.1159.30580","article-title":"Cost of care for individuals with cystic fibrosis: a regression approach to determining the impact of recombinant human DNase","volume":"19","author":"Johnson","year":"1999","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.jcf.2023.11.014_bib0044","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1569-1993(03)00024-9","article-title":"Cost of care and clinical condition in paediatric cystic fibrosis patients","volume":"2","author":"Baumann","year":"2003","journal-title":"J Cyst Fibros"},{"issue":"10","key":"10.1016\/j.jcf.2023.11.014_bib0045","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2165\/00019053-200624100-00007","article-title":"Hospitalisation costs of cystic fibrosis","volume":"24","author":"Schrey\u00f6gg","year":"2006","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.jcf.2023.11.014_bib0046","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1017\/S0266462307080075","article-title":"Valuing care recipient and family caregiver time: a comparison of methods","volume":"24","author":"Guerriere","year":"2008","journal-title":"Int J Technol Assess Health Care"},{"issue":"2","key":"10.1016\/j.jcf.2023.11.014_bib0047","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/11313980-000000000-00000","article-title":"Outpatient medication costs of patients with cystic fibrosis in Germany","volume":"8","author":"Eidt-Koch","year":"2010","journal-title":"Appl Health Econ Health Policy"},{"issue":"8","key":"10.1016\/j.jcf.2023.11.014_bib0048","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/ppul.21441","article-title":"Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001-2007","volume":"46","author":"Briesacher","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"10.1016\/j.jcf.2023.11.014_bib0049","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2165\/11588870-000000000-00000","article-title":"Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre","volume":"30","author":"Heimeshoff","year":"2012","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.jcf.2023.11.014_bib0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jval.2012.12.003","article-title":"Understanding the costs of care for cystic fibrosis: an analysis by age and health state","volume":"16","author":"Van Gool","year":"2013","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jcf.2023.11.014_bib0051","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12325-013-0008-5","article-title":"Cost of cystic fibrosis: analysis of treatment costs in a specialized center in northern Italy","volume":"30","author":"Colombo","year":"2013","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.jcf.2023.11.014_bib0052","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10198-015-0759-9","article-title":"Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study","volume":"18","author":"Ml\u010doch","year":"2017","journal-title":"Eur J Health Econ"},{"issue":"8","key":"10.1016\/j.jcf.2023.11.014_bib0053","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s40273-019-00797-2","article-title":"The economic burden of cystic fibrosis in Germany from a payer perspective","volume":"37","author":"Frey","year":"2019","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.jcf.2023.11.014_bib0054","first-page":"145","article-title":"Hospital costs of Canadian cystic fibrosis patients","volume":"6","author":"Skolnik","year":"2022","journal-title":"Canad J Respirat Crit Care Sleep Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323017228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323017228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:14:55Z","timestamp":1788246895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323017228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1569199323017228"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.11.014","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measuring the burden of cystic fibrosis: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}